Advancements in 2D and 3D In Vitro Models for Studying Neuromuscular Diseases

被引:2
|
作者
Kim, Haneul [1 ]
Kim, Gon Sup [2 ]
Hyun, Sang-Hwan [3 ,4 ,5 ,6 ]
Kim, Eunhye [1 ]
机构
[1] Gyeongsang Natl Univ, Coll Vet Med, Lab Mol Diagnost & Cell Biol, Jinju 52828, South Korea
[2] Gyeongsang Natl Univ, Res Inst Life Sci, Coll Vet Med, Jinju 52828, South Korea
[3] Chungbuk Natl Univ, Vet Med Ctr, Lab Vet Embryol & Biotechnol, Cheongju 28644, South Korea
[4] Chungbuk Natl Univ, Coll Vet Med, Cheongju 28644, South Korea
[5] Chungbuk Natl Univ, Inst Stem Cell & Regenerat Med, Chengju 28644, South Korea
[6] Chungbuk Natl Univ, Grad Sch Vet Biosecur & Protect, Cheongju 28644, South Korea
基金
新加坡国家研究基金会;
关键词
organoid; neuromuscular junction; tissue engineering; neuromuscular disease; MOTOR-NEURONS; BIOMATERIALS; DERIVATION; CELLS; LIVER;
D O I
10.3390/ijms242317006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuromuscular diseases (NMDs) are a genetically or clinically heterogeneous group of diseases that involve injury or dysfunction of neuromuscular tissue components, including peripheral motor neurons, skeletal muscles, and neuromuscular junctions. To study NMDs and develop potential therapies, remarkable progress has been made in generating in vitro neuromuscular models using engineering approaches to recapitulate the complex physical and biochemical microenvironments of 3D human neuromuscular tissues. In this review, we discuss recent studies focusing on the development of in vitro co-culture models of human motor neurons and skeletal muscles, with the pros and cons of each approach. Furthermore, we explain how neuromuscular in vitro models recapitulate certain aspects of specific NMDs, including amyotrophic lateral sclerosis and muscular dystrophy. Research on neuromuscular organoids (NMO) will continue to co-develop to better mimic tissues in vivo and will provide a better understanding of the development of the neuromuscular tissue, mechanisms of NMD action, and tools applicable to preclinical studies, including drug screening and toxicity tests.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] 2D and 3D DOSY methods for studying mixtures of oligomeric dimethylsiloxanes
    Stchedroff, MJ
    Kenwright, AM
    Morris, GA
    Nilsson, M
    Harris, RK
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2004, 6 (13) : 3221 - 3227
  • [22] An In Vitro 3D Model for a Neuromuscular Junction
    Uzel, S.
    Pearl, T.
    Kamm, R. D.
    TISSUE ENGINEERING PART A, 2015, 21 : S77 - S77
  • [23] 2D or not 2D That is the Question, but 3D is the, answer
    Cronin, Paul
    ACADEMIC RADIOLOGY, 2007, 14 (07) : 769 - 771
  • [24] ADVANCES IN 2D AND 3D IN VITRO SYSTEMS FOR HEPATOTOXICITY TESTING
    Hammad, Seddik
    EXCLI JOURNAL, 2013, 12 : 993 - 996
  • [25] Development of 2D and 3D functional platforms for integrated neuromuscular junction studies
    Prime, Stuart
    Springe, Signe
    Paredes, Amaia
    Wallbank, David
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123
  • [26] 3D and 2D/3D holograms model
    A. A. Boriskevich
    V. K. Erohovets
    V. V. Tkachenko
    Optical Memory and Neural Networks, 2012, 21 (4) : 242 - 248
  • [27] Neurovascular interactions in 2D and 3D skin equivalent models
    Rovini, Amandine
    Siadous, Robin
    Bordes, Sylvie
    Closs, Brigitte
    Leng, Jacques
    Berthod, Francois
    Amedee, Joelle
    Desmouliere, Alexis
    WOUND REPAIR AND REGENERATION, 2022, 30 (05) : A16 - A16
  • [28] Using 3D Models to Recognize 2D Faces in the Wild
    Masi, Iacopo
    Lisanti, Giuseppe
    Bagdanov, Andrew D.
    Pala, Pietro
    Del Bimbo, Alberto
    2013 IEEE CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION WORKSHOPS (CVPRW), 2013, : 775 - 780
  • [29] On the validation of DEM and FEM/DEM models in 2D and 3D
    Xiang, Jiansheng
    Munjiza, Antonio
    Latham, John-Paul
    Guises, Romain
    ENGINEERING COMPUTATIONS, 2009, 26 (06) : 673 - 687
  • [30] Dynamical Study of 2D and 3D Barred Galaxy Models
    Manos, T.
    Athanassoula, E.
    CHAOS IN ASTRONOMY, CONFERENCE 2007, 2009, : 115 - +